Patents by Inventor Ahren I. Green

Ahren I. Green has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CB2 RECEPTOR LIGANDS FOR THE TREATMENT OF PAIN
    Publication number: 20120004222
    Abstract: The present invention relates to compounds represented by Formula (I) and Formula (II): or pharmaceutically acceptable salts thereof. The present invention also provides pharmaceutical compositions comprising the instant compounds. This invention further provides methods to treat and prevent pain, respiratory and non-respiratory diseases.
    Type: Application
    Filed: August 18, 2008
    Publication date: January 5, 2012
    Inventors: Zhicai Wu, Ahren I. Green, Jonh C. Hartnett
  • Thiazole Derivatives as CXCR3 Receptor Modulators
    Publication number: 20090143413
    Abstract: The invention encompasses compounds of Formula I (I) or pharmaceutically acceptable salts thereof, which are antagonist of the CXCR3 chemokine receptor useful for the treatment or prevention of pathogenic inflammatory processes, autoimmune diseases or graft rejection processes. Methods of use and pharmaceutical compositions are also encompassed.
    Type: Application
    Filed: November 22, 2006
    Publication date: June 4, 2009
    Inventors: Alan D. Adams, Ahren I. Green, Jason W. Szewczyk
  • Therapeutic compounds for treating dyslipidemic conditions
    Patent number: 7125865
    Abstract: The present invention relates to novel LXR ligands of Formula I and the pharmaceutically acceptable salts, esters and tautomers thereof, which are useful in the treatment of dyslipidemic conditions, particularly depressed levels of HDL cholesterol.
    Type: Grant
    Filed: July 21, 2003
    Date of Patent: October 24, 2006
    Assignee: Merck & Co., Inc.
    Inventors: A. Brian Jones, Alan D. Adams, Ahren I. Green, Shaei Y. Huang, Bruno Tse, Clare E. Gutteridge, Yuan Cheng
  • Therapeutic compounds for treating dyslipidemic conditions
    Publication number: 20040266849
    Abstract: The present invention relates to novel LXR ligands of Formula (I) and the pharmaceutically acceptable salts and esters thereof, which are useful in the treatment of dyslipidemic conditions, particularly depressed levels of HDL cholesterol.
    Type: Application
    Filed: June 15, 2004
    Publication date: December 30, 2004
    Inventors: Alan D Adams, Shaei Y Huang, Bruno Tse, Ahren I Green, A Brian Jones